Skip to main content
Clinical Trials/CTRI/2022/12/048001
CTRI/2022/12/048001
Recruiting
Phase 2

THE EFFECT OF HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF PATIENTS WITH AZOOSPERMIA A PROSPECTIVE QUASI EXPERIMENTAL STUDY

GOKUL KRISHNAN GS0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N460- Azoospermia
Sponsor
GOKUL KRISHNAN GS
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
GOKUL KRISHNAN GS

Eligibility Criteria

Inclusion Criteria

  • Male patients in the age group of 21\-50 years.
  • Patients presenting with azoospermia in their semen analysis ( no sperms in atleast two semen samples obtained more than two weeks apart)
  • Patients presenting with both obstructive and non\-obstructive azoospermia

Exclusion Criteria

  • Patients taking other treatments for infertility.
  • Patients with oligozoospermia, asthenozoospermia,teratozoospermia and aspermia
  • Age below 21 and above 50 years
  • Patients with Genetic defects like Klinefelterâ??s syndrome.
  • Patients with diseases like Accessory sex gland infection, Sexually transmitted diseases.
  • Patients with Diabetes Mellitus.
  • Patients who had chemotherapy and radiotherapy six months prior to the study.
  • Patients consuming alcohol ( More than 4 drinks any day of the week or more than 15 drinks per week)

Outcomes

Primary Outcomes

Not specified

Similar Trials